Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_assertion description "[Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_assertion evidence source_evidence_literature NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_assertion SIO_000772 21471514 NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_assertion wasDerivedFrom befree-20140225 NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_assertion wasGeneratedBy ECO_0000203 NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.
- befree-20140225 importedOn "2014-02-25" NP362864.RA_4y703k-bVyEhcRQ8QAGHFn-J5ysdo6sL348tr64wms130_provenance.